Cargando…
Gene therapy of renal cancer using recombinant adeno-associated virus encoding human endostatin
Renal cell carcinoma (RCC) is characterized by robust angiogenesis during tumor development. Various therapies are not able completely eradicated tumor relapse. The present study targeted angiogenesis and developed a recombinant adeno-associated virus (rAAV) vector containing human endostatin gene f...
Autores principales: | Sun, Erlin, Han, Ruifa, Lu, Bingxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096181/ https://www.ncbi.nlm.nih.gov/pubmed/30127864 http://dx.doi.org/10.3892/ol.2018.9036 |
Ejemplares similares
-
Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
por: Zhao, Liyuan, et al.
Publicado: (2023) -
Antiangiogenic effects of recombinant human endostatin in lung cancers
por: He, Lang, et al.
Publicado: (2018) -
Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy
por: Kotulska, Katarzyna, et al.
Publicado: (2021) -
Pharmacology of Recombinant Adeno-associated Virus Production
por: Penaud-Budloo, Magalie, et al.
Publicado: (2018) -
Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes
por: McClements, Michelle E., et al.
Publicado: (2017)